(Q33365197)

English

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma (English)

1 reference

Europe PubMed Central

26 July 2017

phase II clinical trial

0 references

anaplastic astrocytoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Marc Pipas

1

1 reference

Europe PubMed Central

26 July 2017

Louise P Meyer

2

1 reference

Europe PubMed Central

26 July 2017

C Harker Rhodes

3

1 reference

Europe PubMed Central

26 July 2017

Laurence D Cromwell

4

1 reference

Europe PubMed Central

26 July 2017

Carol E McDonnell

5

1 reference

Europe PubMed Central

26 July 2017

Linda S Kingman

6

1 reference

Europe PubMed Central

26 July 2017

James R Rigas

7

1 reference

Europe PubMed Central

26 July 2017

Camilo E Fadul

8

1 reference

Europe PubMed Central

26 July 2017

publication date

1 February 2005

1 reference

Europe PubMed Central

26 July 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

26 July 2017

71

1 reference

Europe PubMed Central

26 July 2017

3

1 reference

Europe PubMed Central

26 July 2017

301-305

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1007/s11060-004-2026-2

0 references

Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group 9513.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic interaction between topotecan and microtubule-interfering agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage chemotherapy with paclitaxel for recurrent primary brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of topotecan for pediatric patients with malignant solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topoisomerase inhibitors. A review of their therapeutic potential in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a North American Brain Tumor Consortium report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/15735921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-004-2026-2

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33365197&oldid=1961017603"